ARCT - Arcturus Therapeutics Ltd.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Total Operating Expenses25,16719,69833,07810,290
Operating Income or Loss-25,167-19,698-33,078-10,290
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes-25,167-19,698-33,078-10,290
Interest Expense----203
Income Before Tax----
Income Tax Expense7351-1761
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-24,603-19,449-32,834-10,548
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----